Indonesia's exports of basic pharmaceutical products and pharmaceutical preparations to Russia have shown significant variations over the years. After fluctuating between 2013 and 2017, marked by extreme growth rates, exports surged dramatically in 2018. Subsequent years (2019–2023) showed more stability, with a notable peak in 2018 followed by modest growth. By 2023, exports stood at $44.944 million. Year-on-year growth in 2022 and 2023 was relatively moderate at 0.64% and 5.26% respectively, aligning with a CAGR of 0.88% over the last five years.
Looking ahead, forecasts suggest a gradual upward trend with a 5-year CAGR forecast of 3.28%, projected to culminate in exports reaching $55.601 million by 2028. Future trends to watch for include the impact of geopolitical developments on trade relations, potential regulatory changes in both countries, and emerging market demands that may influence export volumes and value.
